Back to 
Avoro Capital Advisors LLC
Avoro Capital Advisors LLC
TVTX
Showing 0 of 3 quarters
Position history for Avoro Capital Advisors LLC's holdings in TRAVERE THERAPEUTICS INC
No. Avoro Capital Advisors exited its TVTX (Travere Therapeutics) position in Q2 2021. Its Q1 2021 13F listed 1,249,000 shares worth $31.2M. Avoro Capital Advisors already held TVTX in its Q4 2020 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.